Search

The interaction of the antitumor drug cisplatin with insulin was studied using a top-down mass spectrometric approach. In vitro incubations were prepared under acidic and physiological conditions at different insulin/cisplatin molar ratios for different incubation times. Size exclusion chromatography--inductively coupled plasma mass spectrometry (SEC--ICPMS) analysis enabled the specific detection of platinum containing species attributed to the binding of the drug to the protein. Further analysis through matrix-assisted laser desorption ionization-time-of-flight mass spectrometry (MALDI-TOF MS) and nanoelectrospray ionization mass spectrometry using a linear ion trap (nESI-LIT-MS) allowed the identification of platinated mono-, di-, and even triadducts in the incubations. Platinum binding sites were identified by [CID-MS.sup.n] as B chain N-terminus, His5, and probably His10 residues, which turned out to be the same, regardless of the incubation conditions. Evidence on the binding of Pt to B chain Cys7 was also observed. Working with the LIT zoom scan mode provides enough resolution to discern the isotopic pattern for both precursor and fragment ions, allowing the differentiation of platinum-containing ions. The elucidation of platinum binding sites in a native protein through a top-down approach has been performed for the first time with this type of instrument.

Several field trials have been carried out to assess the performance of the passive sampler Chemcatcher as aquatic monitoring technology for inorganic mercury and the organotin pollutants monobutyltin (MBT), dibutyltin (DBT) and tributyltin (TBT) in different types of waters across ten locations in Europe. Two version of the sampler were used. One for mercury that consists on 47 mm Empore™ disks of iminodiacetic chelating groups as the receiving phase overlaid by a diffusion membrane of polyethersulphone; and other for organotin compounds comprising a C18 disk and a cellulose acetate membrane. Both membranes were held in a disposable polycarbonate body. The two samplers were calibrated in the laboratory in a previous work to estimate the pollutant concentration. For field sampling, the samplers were deployed for 14 days. In parallel spot samples were periodically collected during the deployment period for comparison purposes. No significant biofouling on the samplers was observed for the locations monitored. In general, water concentrations estimated by Chemcatcher were lower than those found in spot water samples due to the device only collected the soluble bioavailable fraction of target pollutants. However, the pre-concentration capability of Chemcatcher allowed the determination of the tested pollutants at levels where spot sampling fails, even in difficult water bodies such as sewage treatment plants. These advantages lead to consider this emerging methodology as a complementary tool to traditional spot sampling. [ABSTRACT FROM AUTHOR]